Blog

March is Liver Health Month

Opioid use disorder treatment without Hepatitis C care puts you at risk  March is Liver Health Month in Canada, when we’re all reminded to think about our livers and the various behaviours that effect the health of this vital organ. For people who inject drugs, getting screened regularly for Hepatitis C (a common disease that […]

Continue Reading

Pharmacy Appreciation Month

Our pharmacists are helping end the overdose crisis in Canada  March is Pharmacy Appreciation Month in Canada, when we all take the time to acknowledge the incredibly important role pharmacy teams play in providing health care close to home. Most of us live within 5 kms of a pharmacy, making pharmacists pillars of care in […]

Continue Reading

Myths About Hepatitis C

This article is clinically reviewed by Brittany Domm, R.P.N   Hepatitis C is a viral infection that causes inflammation and damage to the liver. It is mainly spread through contact with an infected person’s blood, such as sharing needles for injection drug use or getting a blood transfusion. While viral hepatitis is one of the more […]

Continue Reading

CBC News speaks with GreeneStone’s Program Manager about overdose deaths in Simcoe / Muskoka

Ontario Provincial Police issued a warning in early 2023 about a “highly potent and potentially fatal strain” of illicit opioid possibly circulating in the Simcoe-Muskoka region. CBC News reporter Talia Ricci speaks with experts about the region’s opioid crisis, including Jeremy McIvor, Program Manager at GreeneStone Centre for Recovery. “In remote locations, accessibility to care […]

Continue Reading

Congratulations on Danielle McCarron’s 2022WOI Difference Maker Award!

Presented by the Universal Womens Network, Danielle McCarron has been recognized with the Difference Maker Award for her extraordinary commitment to helping others and for making an impact while leading with purpose. As Vice President of Inpatient and Virtual programs at CATC, Danielle oversees the continuous improvement and development of intensive inpatient and virtual treatment […]

Continue Reading

CSAM Scientific Conference presentation on Hep C care innovations

Recently, at the annual Canadian Society of Addiction Medicine (CSAM-SMCA) 2022 Scientific Conference, we presented on how we were able to improve Hepatitis C (HCV) care at scale during the COVID-19 pandemic using several innovative, tech-based interventions.  As Canada’s trusted community partner for opioid agonist treatment (OAT) CATC offers seamless HCV screening and linkage to […]

Continue Reading